Answers are grounded in this paper and cite their sources.
Introduction In chickens, B cell receptor (BCR) diversity is generated primarily through gene conversion rather than V(D)J recombination. Unlike in mammals, RAG1 haploinsufficiency impairs chicken B cell development and subsequent gene conversion, indicating an avian-specific dosage requirement. However, the precise contribution of RAG2 to this developmental process remains unclear. Methods To address this, we generated RAG2 -disrupted chickens using CRISPR/Cas9-mediated genome editing in primordial germ cells. Results and discussion At 1-week of age, V(D)J recombination was not detected under the conditions used in RAG2 homozygous knockout ( RAG2 -/- ) chickens, whereas wild-type and heterozygous knockout ( RAG2 +/- ) birds showed comparable activity. Histological analysis revealed impairment of bursal, thymic and splenic development in RAG2 -/- chickens. Consequently, B and T cell populations were severely reduced, indicating that complete RAG2 loss blocks mature lymphocyte development, mirroring RAG1 deficiency. However, unlike RAG1 +/- chickens, RAG2 +/- chickens displayed non-significant alteration of BCR downstream signaling and antibody diversification through gene conversion. This is attributed to RAG1 ’s dosage-dependent role in maintaining gene expression associated with B cell identity, and subsequent chromatin regulators essential for gene conversion, a function not shared by RAG2 . These findings reveal a unique, asymmetric dosage requirement for RAG1 and RAG2 during avian B cell development that fundamentally diverges from the mammalian paradigm.
No takes yet. Share an insight, caveat, or question.
Woo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: